MEGGLE presents the new DPI product InhaLac® 180 at RDD Europe 2023
Wasserburg, Germany, May, 2023:
Pharmaceutical lactose specialist MEGGLE Excipients will launch its latest inhalable milled lactose grade, InhaLac® 180 at May’s Respiratory Drug Delivery (RDD) in the South of France.
InhaLac® 180 is tailored to dry powder inhalation (DPI) applications with a highly uniform particle size distribution (PSD) of X10=5-15µm, X50=50-100µm, and X90=120-160µm and characterized by the typical flow and surface characteristics of milled lactose.
Expanding developer’s tool box
With the launch, the quality of MEGGLE‘s lactose excipient meets a specific customer need while expanding the toolbox for developers. “This is a very popular and frequently used PSD distribution in the DPI industry,” comments Katja Milkreiter, MEGGLE Project Manager for DPI, who was significantly involved in the development of this product.
“This new grade should open the way for further DPI developments
and help generic formulation developers to meet the requirements”
Dr. Constanze Müller, MEGGLE Business Development Manager Inhalation
Driving DPI development forward
“This new grade should open the way for further DPI developments and help generic formulation developers to meet the requirements,” added Dr. Constanze Müller, MEGGLE Business Development Manager Inhalation, who will also be present at the RDD conference. “This is a significant expansion of our portfolio that allows us to position ourselves more broadly in the market,” explained Dr. Constanze Müller.
Download the full Press Release Article here: PressRelease_InhaLac180
The Business Unit Excipients produces pharmaceutical excipients for direct compression, granulation, capsules, sachets, powder blends and dry powder inhalers. With its broad product portfolio, intelligent innovations, and exceptional product quality, MEGGLE plays a leading role in the global pharmaceutical excipients business.
With production facilities in Wasserburg (Germany) and Le Sueur, Minnesota (USA), where the requirements of the North American market are served, MEGGLE is prepared to meet customer expectations worldwide.
How does the new InhaLac® 180 fit into Meggle´s DPI Product range? See the overview
(click to enlarge)
More information about MEGGLE lactose and InhaLac® 180 here:
- Lactose Brochure Meggles alpha-lactose monohydrate qualities for dry powder inhalation_lactose brochure
- InhaLac® 180 Poster Meggle_InhaLac180_Poster_A3
- InhaLac® 180 Technical brochure InhaLac_180_Technical Brochure